PURPOSE OF REVIEW: Diabetes resolves in 80% of individuals undergoing successful Roux-en-Y gastric bypass. Absolute caloric restriction alone resulting from gastric anatomic changes indeed leads to weight loss; however, immediate effects in glycemic control often precede substantial weight loss typically associated with insulin sensitivity. One putative explanation relates to hormonal effects accompanying Roux-en-Y gastric bypass. We reviewed the existing and recent literature to investigate the hormonal changes accompanying Roux-en-Y gastric bypass. RECENT FINDINGS: Changes in levels of five candidate enteric hormones have been recently associated with early postoperative glycemic control following Roux-en-Y gastric bypass; the strongest effects are seen with variations in glucagon-like peptide-1, glucose-dependent insulinotropic peptide and ghrelin. SUMMARY: The unique hybridization of static anatomic restriction and dynamic absorptive bypass lends a duality to the beneficial effects of Roux-en-Y gastric bypass. This duality likely explains the short-term and long-term resolution of diabetes in patients undergoing Roux-en-Y gastric bypass.
PURPOSE OF REVIEW: Diabetes resolves in 80% of individuals undergoing successful Roux-en-Y gastric bypass. Absolute caloric restriction alone resulting from gastric anatomic changes indeed leads to weight loss; however, immediate effects in glycemic control often precede substantial weight loss typically associated with insulin sensitivity. One putative explanation relates to hormonal effects accompanying Roux-en-Y gastric bypass. We reviewed the existing and recent literature to investigate the hormonal changes accompanying Roux-en-Y gastric bypass. RECENT FINDINGS: Changes in levels of five candidate enteric hormones have been recently associated with early postoperative glycemic control following Roux-en-Y gastric bypass; the strongest effects are seen with variations in glucagon-like peptide-1, glucose-dependent insulinotropic peptide and ghrelin. SUMMARY: The unique hybridization of static anatomic restriction and dynamic absorptive bypass lends a duality to the beneficial effects of Roux-en-Y gastric bypass. This duality likely explains the short-term and long-term resolution of diabetes in patients undergoing Roux-en-Y gastric bypass.
Authors: Alfredo M Carbonell; Luke G Wolfe; Jill G Meador; Harvey J Sugerman; John M Kellum; James W Maher Journal: Surg Obes Relat Dis Date: 2007-12-11 Impact factor: 4.734
Authors: Timothy M Farrell; Stephen P Haggerty; D Wayne Overby; Geoffrey P Kohn; William S Richardson; Robert D Fanelli Journal: Surg Endosc Date: 2009-01-06 Impact factor: 4.584
Authors: Shih-Wen Lin; Neal D Freedman; Albert R Hollenbeck; Arthur Schatzkin; Christian C Abnet Journal: Cancer Epidemiol Biomarkers Prev Date: 2011-03-17 Impact factor: 4.254
Authors: Stefany D Primeaux; Taniya de Silva; Tony H Tzeng; Monica C Chiang; Daniel S Hsia Journal: Rev Endocr Metab Disord Date: 2016-06 Impact factor: 6.514
Authors: Erik P Severson; Jasvinder A Singh; James A Browne; Robert T Trousdale; Michael G Sarr; David G Lewallen Journal: J Arthroplasty Date: 2012-05-02 Impact factor: 4.757
Authors: James M Isbell; Robyn A Tamboli; Erik N Hansen; Jabbar Saliba; Julia P Dunn; Sharon E Phillips; Pamela A Marks-Shulman; Naji N Abumrad Journal: Diabetes Care Date: 2010-04-05 Impact factor: 19.112